PGx testing analyzes an individual’s genetic makeup to predict their response to specific medications. By identifying genetic variations that influence drug metabolism, this testing provides healthcare providers with crucial insights, guiding more informed medication prescriptions and eliminating the need for trial-and-error approach. Hence, PGx testing can improve treatment outcomes and lower the risk of adverse reactions.
Trial-and-error approach involves trying various medical treatments to find the most effective one for a patient when medication responses are unpredictable. For instance, in treating depression, doctors may prescribe different drugs to determine the best match, but this can lead to side effects since it does not consider the patient’s unique genetic makeup.
This testing is beneficial for patients struggling with medication efficacy or experiencing severe side effects. It is also suitable for regular medication reviews, particularly for elderly patients in nursing homes or community settings. Additionally, it serves as a preventative measure for patients starting long-term treatments, including:
It is our testing panel that analyzes 18 key genes relating to drug metabolism for just $193. These genes include:
Are you interested in discovering which medications are metabolized by the genes analyzed in PGx testing?